TC 99m demogastrin 2Alternative Names: 99mTc-Demogastrin 2; Demogastrin; Metastable technetium 99 demogastrin 2
Latest Information Update: 01 Apr 2016
At a glance
- Originator Biomedica Life Sciences; National Center for Scientific Research Demokritos
- Class Radioisotopes; Radiopharmaceutical diagnostics; Technetium compounds
- Mechanism of Action Cholecystokinin B receptor modulators; Diagnostic imaging enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Thyroid cancer
Most Recent Events
- 01 Apr 2016 Phase I development is ongoing in the Netherlands